Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
24.10. | ARPA-H Awards $110M to 23 Startups and Innovators In Women's Health, Jill Biden Announces | ||
24.10. | Strict Abortion Laws Are Likely Already Having An Economic Impact | ||
23.10. | 9 HLTH Announcements You Don't Want to Miss | ||
23.10. | Springboard Enterprises Executive-in-Residence Shares Advice to Startups | ||
23.10. | Video: Why This Startup CEO Never Accepted Outside Capital | ||
23.10. | Alto Neuroscience's Depression Trial Failure Sends Shares Into Downward Spiral | ||
23.10. | Can Herbal Alternatives Ease the Economic Burden of Weight Loss Drugs? | ||
23.10. | Zero Trust: Mitigating Cybersecurity Risks in Digital Medical Ecosystems | ||
23.10. | How Do Employers Address Rising Healthcare Costs? | ||
23.10. | Chelsea Clinton on Reproductive Rights: 3 Things to Know | ||
23.10. | Avandra Imaging Emerges from Stealth to Solve a Last-Mile Problem in Medical Research | ||
22.10. | Editas Medicine Seeks Partner for Ex Vivo Gene-Editing Program as Focus Turns to In Vivo R&D | ||
22.10. | Analyzing the Medicare Advantage Terminations: Concerns, Drivers, and Solutions | ||
22.10. | The Case for Prioritizing the Number One Killer: Cardiovascular Disease | ||
22.10. | Can Primary Care Thrive Outside of Traditional Healthcare Players? | ||
22.10. | Blue Shield of California, Salesforce Partner to Modernize Prior Authorization | ||
21.10. | Astellas Pharma Lands a First-in-Class Drug Approval in Rare Gastrointestinal Cancer | ||
21.10. | How the Move of Ablation Procedures into Surgery Centers Will Transform Electrophysiology | ||
21.10. | The Funding Model for Cancer Innovation is Broken - We Can Fix It | ||
21.10. | Why Greg Adams Believes Risant Health Will Be Successful In Its Mission to Scale VBC Across the Country | ||
21.10. | How the Dobbs Decision Impacts Medical Practice Beyond Just OBGYNs | ||
20.10. | How Generative AI Will Find a Place in the Pharma Industry Now and in the Years to Come | ||
20.10. | Why Harris' Medicare at Home Plan is Good but Flawed | ||
20.10. | Investing in Reproductive Health Companies Post-Dobbs: A Moral and Strategic Imperative | ||
18.10. | New Study Shows That Waymark Reduces ED, Hospital Visits for Medicaid Patients |